Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06172023
Other study ID # (RHDIRB2017122004) (438)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date March 1, 2023

Study information

Verified date December 2023
Source Minia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Silver nanoparticles possess unique physicochemical and biological properties in addition to their antibacterial capabilities. Similarly, zinc oxide nanoparticles have demonstrated antibacterial effects against a wide range of bacteria, including heat and pressure resistant spores. Given these characteristics, it would be valuable to evaluate and compare a new irrigation solution containing nanosilver and nanozinc-oxide particles with sodium hypochlorite. Furthermore, Chitosan Nanoparticles are expected to exhibit enhanced antibacterial activity compared to regular-sized Chitosan due to their ability to penetrate and disrupt microbial cell membranes. Consequently, the current study aims to assess and compare the antibacterial activity of Silver Nanoparticles and Chitosan Nanoparticles, as well as their impact on post-operative pain.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date March 1, 2023
Est. primary completion date December 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - Medically stable healthy patients (category: American society of anesthesiologists class I). - The patient ranges in age from 20 to 40. - No sexual orientation - Necrotic pulp evaluated by thermal or electrical pulp testing. - Enough crown structure to provide adequate isolation. - One root and one canal. - Patients' desire to engage in this research. - Patients' comprehension of the visual analogue scale (VAS). - Patients' ability to sign informed consent. Exclusion Criteria: - Endodontic treatment for the tooth previously. - Teeth with poor conditions for using rubber dams. - Vital pulp tissue was observed throughout the treatment. - Patients who have a medical condition. - Teeth with open apices that are immature - Women who are pregnant or breastfeeding. - Psychologically disturbed patients. - Patients having a history of allergy to any of the research drugs were barred from participation. - A periodontally affected tooth with grade 2 or 3 mobility.

Study Design


Intervention

Drug:
Silver Nanoparticles Irrigant
Nanosilver irrigant solution
Chitosan Nanoparticles Irrigant
Chitosan nanoparticles irrigant solution

Locations

Country Name City State
Egypt Faculty of Dentistry, Minia University Minya

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative Pain Assessment Each patient was given a pain scale chart (VAS scale) before every endodontic operation to record his or her pain level. The VAS is a 10-point scale with values ranging from 0 to 10, with 0 representing "No pain," (1-3) representing "mild pain," (4-6) representing "moderate pain," and (7-10) representing "worst imaginable pain." At 6, 12, 24, 48, and 72 hours, each patient was instructed to use the VAS scale (0-10) to rate the presence and severity of discomfort after obturation. 6, 12, 24, 48, and 72 hours
Secondary Antimicrobial Activity Assessment A sterile paper point was placed in each root canal to a level roughly 1 mm short of the apex, depending on working length radiographs, to get a sample from the root canal. The samples were suspended in a suspension of 25 microliters, which was pipetted onto a BHI agar plate. The colonies were counted using a Reichert-Jung colony counter after 1 hour, 24 hours, 7 days, and 30 days of incubation at 37oC in an anaerobic jar. 1 hour, 24 hours, 7 days, and 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT05338671 - Effect of Post-Operative Anesthetics on Post-Operative Pain in Patients Receiving Endodontic Treatment Phase 4
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Recruiting NCT04528979 - Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer N/A
Recruiting NCT04527705 - Outcome of Endodontic Retreatment in One or Two Visits N/A
Completed NCT04102293 - Time Efficiency and Obturation Quality of Rotary Versus Manual in Primary Teeth N/A
Completed NCT03635515 - Occurrence of Post-op Pain Following Gentlewave N/A
Completed NCT04211519 - Analysis of Bacterial Microbiome of Endodontically Infected Primary and Permanent Teeth N/A
Recruiting NCT05959629 - Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection N/A
Recruiting NCT04471558 - Effect of Music on Young Practitioner's Stress During Endodontic Treatment
Active, not recruiting NCT05555043 - Comparison of Clinical Outcomes Between GentleWave® and Biolase® N/A
Completed NCT04109417 - Effect of Platelet-Rich Plasma Biomembrane on Enhancing Bone Regeneration Following Endodontic Surgery N/A
Completed NCT04462731 - Post-endodontic Pain Survey N/A
Not yet recruiting NCT05935306 - Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery N/A
Not yet recruiting NCT05681754 - Endo-perio Disease - Treatment Outcomes Using Conventional and Hydraulic Calcium Silicate Sealer With or Without LPRF N/A
Active, not recruiting NCT05612451 - Outcome of Regenerative Endodontic Procedures N/A
Completed NCT03042377 - Postoperative Pain in Single-visit and Multiple-visit Retreatment Cases Phase 4
Completed NCT04617301 - Volumetric Analysis of Resorption Types on CBCT
Not yet recruiting NCT06439212 - the Efficacy of Ginger Powder as an Analgesic for Intraoperative and Post- Endodontic Pain Management Phase 3
Recruiting NCT03451435 - N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization Early Phase 1
Completed NCT04481945 - Evaluation of Antimicrobial Efficacy and Adaptability of Bioceramic Sealer Containing Nanoparticles Phase 4